Join to view full profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Dr. Okuno is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Scott Okuno, MD, is an oncology specialist in Rochester, MN, with a focus on sarcomas. He completed his medical education at the University of Illinois College of Medicine in 1989, followed by a residency in internal medicine and a fellowship in hematology and medical oncology at Mayo Clinic College of Medicine and Science. Dr. Okuno holds leadership positions, including Chair of Department of Hematology Oncology at Mayo Clinic Health System, Chief Medical Officer of SARC, and NRG sarcoma working group co-chair of sarcoma subcommittee. His research includes numerous publications on sarcoma treatments and participates in clinical trials, often as a principal investigator.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1992 - 1996- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1989 - 1992
University of Illinois College of MedicineClass of 1989
Certifications & Licensure
NH State Medical License 2012 - Present
IL State Medical License 2012 - 2029
FL State Medical License 2014 - 2028
ND State Medical License 2012 - 2028
MT State Medical License 2012 - 2028
AZ State Medical License 2014 - 2027
WI State Medical License 1996 - 2027
American Board of Internal Medicine Medical Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise, GE Healthcare, 2014-2017
- CMS Meaningful Use Stage 2 Certification Centricity Enterprise (CE), GE Healthcare, 2014-2017
- CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2014-2017
Clinical Trials
- Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
- Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Publications & Presentations
PubMed
- ASO Visual Abstract: Improved Oncologic Outcomes with Trimodality Therapy for Radiation-Associated Angiosarcoma of the Breast.Saskia J Leonard, Tanya Hoskin, Brittany L Siontis, Safia Ahmed, Tina J Hieken
Annals of Surgical Oncology. 2026-10-01 - Improved Oncologic Outcomes with Trimodality Therapy for Radiation-Associated Angiosarcoma of the Breast.Saskia J Leonard, Tanya Hoskin, Brittany L Siontis, Safia Ahmed, Tina J Hieken
Annals of Surgical Oncology. 2026-10-01 - Management of Soft Tissue and Visceral Leiomyosarcomas.Fernando Campos, Rebecca Gladdy, Annie Achee, Mitch Achee, Kenneth Cardona
JAMA Oncology. 2026-09-10
Journal Articles
- Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients with Hereditary Cancer SyndromeScott Okuno, Luke Mountjoy, Cameron S Thorpe, Edward D Esplin, Robert L Nussbaum, Alan H Bryce, Tanios S Bekaii-Saab, Aleksandar Sekulic, JAMA Oncology
Press Mentions
Salarius Pharmaceuticals Adds Two Mayo Clinic Sites to Its Ongoing Phase 1/2 Trial of Seclidemstat as a Treatment for Ewing’s Sarcoma and FET-Rearranged SarcomasAugust 22nd, 2022- Surprise Wedding Shower 1,000 Miles from HomeAugust 8th, 2022
Innovative Treatment Moves Conner Beyond CancerSeptember 23rd, 2019
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
